SCHEMBL9865701

SCHEMBL9865701

NCCCSc1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
KMT2A Q03164 3/20 0.50
HRH1 P35367 2/20 0.50
MAPT P10636 2/20 0.50
EHMT2 Q96KQ7 1/20 0.48
EHMT1 Q9H9B1 1/20 0.48
APOBEC3G Q9HC16 1/20 0.48
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.42
PKM P14618 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
HPGD P15428 1/20 0.42
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8615154 0.98 ALDH1A1 (0.53) ALDH1A1KMT2AHRH1MAPTEHMT2
SCHEMBL9081971 0.94 HRH1 (0.53) ALDH1A1KMT2AHRH1MAPTEHMT2
SCHEMBL1743337 0.93 HRH1 (0.56) ALDH1A1KMT2AHRH1MAPTEHMT2
SCHEMBL317308 0.88 ALDH1A1 (0.58) ALDH1A1KMT2AHRH1MAPTEHMT2
Hydrochloric Acid SCHEMBL4286924 0.86 ALDH1A1 (0.56) ALDH1A1KMT2AHRH1MAPTEHMT2
Hydrochloric Acid SCHEMBL1268501 0.86 ALDH1A1 (0.56) ALDH1A1KMT2AHRH1MAPTEHMT2
SCHEMBL10974209 0.82 ALDH1A1 (0.56) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL10802711 0.81 EHMT2 (0.55) ALDH1A1KMT2AHRH1MAPTEHMT2
SCHEMBL679871 0.81 ALDH1A1 (0.59) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL7812414 0.81 ALDH1A1 (0.54) ALDH1A1KMT2AMAPTEHMT2EHMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023022554-A1 METHOD FOR PREPARING SWELLABLE POLYMER TO WHICH OBJECT IS FIXED 부산대학교 산학협력단 2023-02-23 WO disclosed
EP-2488544-B1 AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION UNIV MONASH (AU) 2015-03-18 EP disclosed
US-8748582-B2 Affinity ligands and methods for protein purification MONASH UNIVERSITY (AU) 2014-06-10 US disclosed
US-8748582-B2 Affinity ligands and methods for protein purification MONASH UNIVERSITY (AU) 2014-06-10 US disclosed
US-20120259094-A1 AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION MONASH UNIVERSITY 2012-10-11 US disclosed
US-20120259094-A1 AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION MONASH UNIVERSITY 2012-10-11 US disclosed
WO-2011044637-A1 AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION MONASH UNIVERSITY (AU) 2011-04-21 WO disclosed
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0040696-B1 AMINOTHIADIAZOLES AS GASTRIC SECRETION INHIBITORS MERCK & CO. INC. (US) 1986-08-27 EP disclosed
US-4438127-A AMIDOFORMIC AND AMIDOSULFONIC ACID HISTAMINE H2 ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-03-20 US disclosed
US-4395419-A ANTIHISTAMINE, ANTISECRETORY AGENT SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-07-26 US disclosed
US-4308275-A ANTIGASTRIC ACID SECRETION, HISTAMINE RECEPTOR ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-12-29 US disclosed
EP-0040696-A2 Aminothiadiazoles as gastric secretion inhibitors MERCK & CO. INC. (US) 1981-12-02 EP disclosed
US-4216318-A HISTAMINE HZ-ANTAGONISTS, ISOCYTOSINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-08-05 US disclosed
US-4189488-A ANTIHISTAMINES AND GASTRIC ANTISECRETORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-02-19 US disclosed
US-4154834-A HETEROCYCLIC-(THIO)ALKYLAMINO SUBSTITUTED-4-PYRIMIDONE OR -THIONES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-15 US disclosed
US-4118502-A ANTIHISTAMINE SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-10-03 US disclosed
US-4080459-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-03-21 US disclosed
US-4067984-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-01-10 US disclosed
US-4013769-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120259094-A1 AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION MAX, SPR, CCL2 ALDH1A1 2415/4885KMT2A 3029/4885HRH1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.